tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TKPHF Stock Latest News

Protagonist Therapeutics price target raised to $100 from $86 at Wedbush
The FlyProtagonist Therapeutics price target raised to $100 from $86 at Wedbush
16d ago
TAK
PTGX
Takeda, Protagonist announce FDA acceptance of rusfertide new drug application
PremiumThe Fly
Takeda, Protagonist announce FDA acceptance of rusfertide new drug application
16d ago
TAK
PTGX
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
PremiumCompany Announcements
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
16d ago
Boston Scientific names Cathy Smith, Christophe Weber to board of directors
PremiumThe Fly
Boston Scientific names Cathy Smith, Christophe Weber to board of directors
23d ago
BSX
TAK
Takeda announces data from Phase 3 KEPLER trial of ENTYVIO
PremiumThe Fly
Takeda announces data from Phase 3 KEPLER trial of ENTYVIO
26d ago
TAK
Takeda granted Priority Review for oveporexton by FDA
PremiumThe FlyTakeda granted Priority Review for oveporexton by FDA
1M ago
TAK
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
Premium
Company Announcements
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
1M ago
Takeda raises FY25 core EPS view to 486 yen from 479 yen
Premium
The Fly
Takeda raises FY25 core EPS view to 486 yen from 479 yen
2M ago
TAK
Takeda reports Q3 core EPS 428 yen vs. 443 yen last year
PremiumThe Fly
Takeda reports Q3 core EPS 428 yen vs. 443 yen last year
2M ago
TAK
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
PremiumCompany Announcements
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
2M ago
TKPHF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TKPHF Upcoming Earnings Report: What to Expect?
2M ago
Takeda announces U.S. availability of Gammagard Liquid ERC
PremiumThe Fly
Takeda announces U.S. availability of Gammagard Liquid ERC
2M ago
TAK
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
RR
ENB
Takeda resumed with an Overweight at Morgan Stanley
Premium
The Fly
Takeda resumed with an Overweight at Morgan Stanley
2M ago
TAK
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
Premium
The Fly
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
2M ago
TAK
HALO
Halozyme announces global collaboration, license agreement with Takeda
PremiumThe Fly
Halozyme announces global collaboration, license agreement with Takeda
2M ago
TAK
HALO
Alumis price target raised to $32 from $18 at Guggenheim
PremiumThe Fly
Alumis price target raised to $32 from $18 at Guggenheim
2M ago
TAK
ALMS
Takeda, Protagonist Therapeutics submit rusfertide new drug application to FDA
PremiumThe Fly
Takeda, Protagonist Therapeutics submit rusfertide new drug application to FDA
2M ago
TAK
PTGX
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
PremiumThe Fly
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
3M ago
TAK
XOMA
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
PremiumThe FlyXoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
3M ago
TAK
XOMA
Leerink says Takeda results signal positive readthrough for Alumis
Premium
The Fly
Leerink says Takeda results signal positive readthrough for Alumis
3M ago
TAK
ALMS
Alumis price target raised to $20 from $14 at H.C. Wainwright
Premium
The Fly
Alumis price target raised to $20 from $14 at H.C. Wainwright
3M ago
TAK
ALMS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >